Diana Dimitrova

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

Experiences of men who attended the birth of their children for the first time

Diana Dimitrova, 2016, Varna Medical Forum.

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

M. Benatar, M. Tosun, M. Kurtoğlu, 2023, The Lancet Neurology.